RegCell
4 known investors
RegCell Biosciences is a biotechnology company developing regenerative cell therapies, leveraging expertise in cell and gene therapy, manufacturing, and immunology to advance therapeutic treatments.
BiotechDeep TechMedical Devices
Founders & leadership
MM
Michael McCullar, PhDChief Executive Officer
JA
James AhlersChief Financial Officer
MG
Marty Giedlin, PhDChief Technology Officer
TH
Tony HurleyChief Technical Operations Officer
SK
Steve Kanner, PhDChief Scientific Officer
Investors · 4
In the news
- Fast Track Initative News | FTI Co-Leads USD 45.8 million Investment in RegCell to Accelerate Development of Treg therapy for Autoimmune Diseasesus.fasttrackinitiative.com · 2025
- RegCell Raises $45.8M for US Expansion of Treg Therapies | PackGene Biotechpackgene.com · 2025
- RegCell opens up cell therapy shop in California with $45M in funding | FirstWord Pharmafirstwordpharma.com · 2025
- Japanese-Founded Regulatory T-cell Reprogramming Company RegCell Secures $45.8M in Funding and Completes U.S. Headquarters Transition - RegCellregcellbio.com · 2025
- RegCell Raises $45.8M in Fundingfinsmes.com · 2025